Depending on how the Amarex settlement talks go/have been going I don't see any reason for us to agree to a buyout until after the inflammation trial. That should be starting relatively soon so unless someone shows up in the next month to buy us (which doesn't seem likely) the share price should have a chance to rebound with a successful trial. Fingers crossed.